Genome & Company (KOSDAQ:314130)
South Korea · Delayed Price · Currency is KRW 2,735.00
-20.00 (-0.73%)
At close: Sep 17, 2025
Genome & Company Market Cap
Genome & Company has a market cap or net worth of 83.78 billion as of September 19, 2025. Its market cap has decreased by -44.07% in one year.
Market Cap
83.78B
Enterprise Value
77.83B
Revenue
24.02B
Ranking
n/a
PE Ratio
n/a
Stock Price
2,735.00
Market Cap Chart
Since December 26, 2018, Genome & Company's market cap has increased from 71.88B to 83.78B, an increase of 16.55%. That is a compound annual growth rate of 2.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 19, 2025 | 83.78B | -1.68% |
| Dec 30, 2024 | 85.21B | -51.64% |
| Dec 28, 2023 | 176.21B | -28.34% |
| Dec 29, 2022 | 245.90B | -47.55% |
| Dec 30, 2021 | 468.83B | -55.28% |
| Dec 30, 2020 | 1,048.46B | 224.28% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 26, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Electronics | 520.34T |
| SK hynix | 243.72T |
| LG Energy Solution | 81.78T |
| Samsung Biologics | 72.88T |
| Hanwha Aerospace | 52.58T |
| Hyundai Motor Company | 46.74T |
| HD Hyundai Heavy Industries | 43.77T |
| KB Financial Group | 42.42T |